integMET
Home
About
Documentation
Diff Profiles
Metabolites
studies
Gragh
Metabolites
›
WYSRACVJQVNCRW-UHFFFAOYSA-N
WYSRACVJQVNCRW-UHFFFAOYSA-N
WYSRACVJQVNCRW-UHFFFAOYSA-N
0 Reactome links
2 studies
2
Observed studies
2
Observed diff profiles
0
Reactome pathways
Metabolite details
Identifier
WYSRACVJQVNCRW-UHFFFAOYSA-N
InChI Key
WYSRACVJQVNCRW-UHFFFAOYSA-N
IUPAC name
Preferred name
WYSRACVJQVNCRW-UHFFFAOYSA-N
INN name
—
Synonym
—
ChEBI
—
Reactome pathways
No Reactome pathways listed for this metabolite.
Observed in studies
Distinct succinate modifying products are clinically diagnostic and prognostic biomarkers for fumarate hydratase deficient renal cell carcinoma
Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19
Observed in differential profiles
Normal_control_no_tumor_vs_FH_deficient_RCC
Mild_vs_Severe